Evidation Health

Evidation Health operates a leading real-world data (RWD) and patient engagement platform that bridges the gap between life sciences research and individuals in their everyday lives. Founded in 2012, the company has established direct connections with over 5 million individuals, enabling the generation of continuous, multimodal data streams—including wearables, patient-reported outcomes, EHR, and molecular data—for research and commercial applications. Its core business model involves licensing its platform to top life sciences companies, healthcare organizations, and government agencies to identify, engage, and retain patient cohorts for long-term studies, thereby accelerating evidence generation and improving health outcomes.

A direct-to-participant research and engagement platform that aggregates and analyzes multimodal real-world data (wearables, PROs, EHR, claims, SDOH, molecular data) from a consented, recontactable cohort of over 5 million individuals. It uses data-driven tactics to achieve high participant retention and protocol compliance for long-term studies.

Evidation competes in the real-world evidence and decentralized clinical trial platform space. Key competitors include large contract research organizations (CROs) like IQVIA and Parexel expanding into digital RWE, dedicated DCT platforms like Medable and Science 37, and large technology firms (Apple, Google/Verily) with health data initiatives. Evidation's differentiation lies in its large, directly-consented, and recontactable member community and its proven engagement engine.